Massachusetts 2025-2026 Regular Session

Massachusetts Senate Bill S465

Introduced
2/27/25  
Refer
2/27/25  

Caption

Supporting individuals suffering with amyotrophic lateral sclerosis and their families

Impact

The bill makes significant changes to the state's healthcare landscape by specifically addressing the needs of ALS patients. It requires a broader scope of healthcare services under the Massachusetts Division of Medical Assistance. The new regulations aim to establish rigorous standards for patient-centeredness in healthcare decision-making processes, ensuring that the needs and preferences of patients, particularly those with disabilities, are prioritized. This approach reflects a shift towards more personalized and responsive healthcare services that take into account individual patient needs.

Summary

Bill S465 aims to enhance support for individuals diagnosed with amyotrophic lateral sclerosis (ALS) in Massachusetts. It mandates that the Executive Office of Elder Affairs amend existing home care regulations to ensure that home care program services are available to ALS patients, regardless of their age, provided they are otherwise eligible for these services. This provision is set to create a more inclusive support system for ALS patients who require home care services, allowing them to receive necessary assistance without the constraints of age-related eligibility criteria.

Contention

Notably, the bill's emphasis on patient-centered standards may provoke discussions regarding the methodologies used in healthcare analyses and the potential implications for cost-management strategies. The prohibition of relying on discriminatory measures, such as cost-effectiveness analyses that quantify health outcomes in economic terms, could also stir debate among stakeholders, including healthcare providers and policymakers. Critics may argue that this might limit the state's ability to manage healthcare costs effectively while advocates will view it as a necessary step toward equitable healthcare access for vulnerable groups.

Summary_overview

In summary, Bill S465 represents a vital legislative effort to improve the quality of life and healthcare access for individuals suffering from ALS in Massachusetts. By focusing on regulatory amendments that ensure comprehensive home care services and implementing standards that uphold patient-centeredness, the bill addresses critical gaps in support for ALS patients and their families. The legislative discourse surrounding the bill reflects broader issues within healthcare policy, highlighting the balance between equitable access and sustainable healthcare financing.

Companion Bills

No companion bills found.

Previously Filed As

MA S730

Advancing health care research and decision-making centered on patients and people with disabilities

MA H1183

Advancing health care research and decision-making centered on patients and people with disabilities

MA S1398

Supporting individuals with intellectual and developmental disabilities including autism

MA H167

To provide a pilot program for low interest loans to families with a child suffering from a terminal illness

MA S610

For supportive care for serious mental illness

MA H989

For supportive care for serious mental illness

MA H3489

Supporting Massachusetts Guard and Reserve and their families

MA S1344

To improve outcomes for individuals with Parkinson’s disease

MA S1234

To provide more focused care to individuals suffering from mental health and substance related disabilities

MA H3568

Supporting families of students with disabilities

Similar Bills

CA AB922

Reproductive health and research: oocyte procurement.

HI SB2304

Relating To The Research Corporation Of The University Of Hawaii.

HI SB3208

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1204

Relating To The University Of Hawaii.

CA SB934

California Childhood Cancer Research Fund Act.

CA AB1103

Controlled substances: research.